Protedyne to Install BioCube System at Correlagen Diagnostics Laboratory
Protedyne Corporation announced that it has been selected by Correlagen Diagnostics, Inc. to provide automation to the Cambridge, MA company. The two companies signed agreements to automate Correlagen's genes That Matter(TM) gene testing service, including the setup of gene sequencing reactions, nucleic acid purification, and cleanup.
"We're delighted to have been chosen by Correlagen as their automation partner. Correlagen is just the type of company that will benefit greatly from Protedyne's total solution approach to automation," said Catherine Williams, Vice President of Sales and Marketing at Protedyne. "The BioCube(TM) System is a perfect complement to the advanced work being done at Correlagen."
"The integration of a BioCube System with Correlagen's proprietary software will enable Correlagen to sequence human genes for clinical diagnostic purposes at very low cost," said David M. Margulies, M.D., Correlagen's Chief Executive Office. "We are impressed with the elegant engineering that Protedyne brings to the processes of laboratory automation and plan to launch our next line of sequencing assays on a BioCube System this fall," added Margulies.
Other news from the department business & finance
